Share Email Print

Journal of Biomedical Optics

Optically tunable nanoparticle contrast agents for early cancer detection: model-based analysis of gold nanoshells
Format Member Price Non-Member Price
PDF $20.00 $25.00

Paper Abstract

Many optical diagnostic approaches rely on changes in scattering and absorption properties to generate optical contrast between normal and diseased tissue. Recently, there has been increasing interest in using exogenous agents to enhance this intrinsic contrast with particular emphasis on the development for targeting specific molecular features of disease. Gold nanoshells are a class of core-shell nanoparticles with an extremely tunable peak optical resonance ranging from the near-UV to the mid-IR wavelengths. Using current chemistries, nanoshells of a wide variety of core and shell sizes can easily be fabricated to scatter and/or absorb light with optical cross sections often several times larger than the geometric cross section. Using gold nanoshells of different size and optical parameters, we employ Monte Carlo models to predict the effect of varying concentrations of nanoshells on tissue reflectance. The models demonstrate the importance of absorption from the nanoshells on remitted signals even when the optical extinction is dominated by scattering. Furthermore, because of the strong optical response of nanoshells, a considerable change in reflectance is observed with only a very small concentration of nanoshells. Characterizing the optical behavior of gold nanoshells in tissue will aid in developing nanoshells as contrast agents for optical diagnostics.

Paper Details

Date Published: 1 November 2005
PDF: 10 pages
J. Biomed. Opt. 10(6) 064035 doi: 10.1117/1.2141825
Published in: Journal of Biomedical Optics Volume 10, Issue 6
Show Author Affiliations
Alex Wei Han Lin, Rice Univ. (United States)
Nastassja A. Lewinski, Rice Univ. (United States)
Jennifer L. West, Rice Univ. (United States)
Naomi J. Halas, Rice Univ. (United States)
Rebekah Anna Drezek, Rice Univ. (United States)

© SPIE. Terms of Use
Back to Top